E-Newsletter - August 2018
CALL FOR ABSTRACTS
CLINICAL RESEARCH PROFESSIONALS + ONCOLOGY NURSES
The Alliance Clinical Research Professionals (CRP) and Oncology Nursing (A-ONC) committees are seeking abstracts for the poster session at the upcoming 2018 Alliance Fall Group Meeting November 1-3, in Chicago, IL.
This is an opportunity for Alliance sites to share their success stories in adapting to ever-changing regulatory requirements, training programs for new staff, implementation of new processes and clinical management of patients who are receiving treatment.
Two abstracts (one CRP focused; one nursing focused) will be selected for a three- to 10-minute oral presentation during the CRP/Oncology Nursing Roundtable Session taking place Friday, November 2. All abstracts submitted will be eligible and considered for selection for the two oral sessions. Authors whose abstracts are accepted will be asked to create a poster that will be displayed during the Alliance Group Meeting Poster Session later on that Friday evening.
Submission Categories
Please indicate the category of the abstract submission.
-- Regulatory
-- Training
-- Work Processes
-- Side Effect/Clinical Management
Submission Requirements
1. The abstract's primary author must be from an Alliance member site.
2. The abstract word limit is 800 words, not including the title, author names, and affiliations.
3. The abstract may include up to four graphic elements (e.g., a photo, illustration, table or graph) no larger than 4" X 6".
4. Abstracts should be logically organized and be related to one of the four submission categories listed above. Abstracts that do not conform to these guidelines will not be considered for acceptance and no further review will be done.
5. Abstracts should be sent by e-mail as a Microsoft Word file to Anna Weiss, MD (aweiss5@bwh.harvard.edu). All abstracts submitted should be ready for publication. Include the first author's last name and the abstract title in the file name. For example: Miller_Data_submission_ timeliness_suggestions.docx
6. The abstract due date is Friday, September 14, 2018. Absolutely no late abstracts will be accepted. Abstracts submitted after the deadline will not be considered.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Frequently Asked Questions
Q1: Why should I submit an abstract?
Abstracts can be a helpful tool to give other Alliance sites ideas about how to improve processes or the quality of research conducted at their sites.
Q2: How will the abstracts be reviewed and selected for presentation at the meeting?
Abstracts will be reviewed by a selection committee comprised of an Alliance Executive Officer and two representatives each from both CRP and A-OCN committees. All abstracts will be de-identified during the review and selection process.
Q3: When will applicants be notified which abstracts were selected?
All applicants will be notified by e-mail Friday, September 21 of the status of their abstract.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Tips for Writing an Abstract and Creating a Poster
Click link to download the tip sheet.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Sample Posters: CRP/A-OCN Spring 2018 Presentations
Byatt Poster
Moxon Poster
Crow Poster
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Alliance Poster Template
Click link to download the Alliance 4X6 poster template.
For other articles in this issue of the Alliance E-News newsletter, see below.
-
Spotlight on Trials
Three New Alliance Protocol Activations
Update - Two Trials Focus on Rare Population Subsets: Alliance A091302 and Alliance A091305 -
Alliance in the News
From Cattle Rancher to ASCO President: Monica Bertagnolli, MD, on her motivations and goals
Geoffrey Uy, MD, to Lead Pivotal Phase III Trial for Patients with Acute Myeloid Leukemia (AML)
Comparative Effectiveness of Decision Aids in Diverse Populations with Prostate Cancer (Alliance 191402CD)
Associations of Artificially Sweetened Beverage Intake with Disease Recurrence and Mortality in Colon Cancer (CALGB 89803) -
Guest Columnists
Richard M. Stone, MD - Intergroup Collaboration Emphasized in Era of Many New Drugs in Leukemia
Alison Conlin, MD - Cancer Research in the Beautiful Pacific Northwest
Disparities Corner | Haejin In, MD, MBA, MPH, FACS - Identifying Gastric Cancer Risk Through Cancer Disparities -
Announcements
Call for Nominations: Charles G. Moertel Lecturer
Call for Abstracts: CRPs and Oncology Nurses
In Memoriam: Alliance Patient Advocates - Robert Harrison and Hank Porterfield -
Fall Group Meeting
Schedule Now Available
Registration Opens Late August -
#Did You Know
About Meeting Materials from May 2018 (public site) or (member site)
About Deadlines for Alliance Abstracts
About Alliance Foundation Trials